Edgestream Partners »

Intra Cellular Therapies shares owned by Edgestream Partners

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Edgestream Partners from 13F filings

Historical chart of Edgestream Partners investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Edgestream Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Edgestream Partners

Quarter filed Position value Share count Share price at filing
2024-12-31 $304k 3.6k 83.52
2024-09-30 $4.0M 55k 73.17
2024-03-31 $1.3M 18k 69.20
2023-12-31 $962k 13k 71.62
2023-09-30 $2.3M 44k 52.09
2023-06-30 $1.5M 24k 63.32

More positions owned by Edgestream Partners

Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Marsh & McLennan Companies (MMC)
Bank of New York Mellon Corporation (BK)
Exxon Mobil Corporation (XOM)
Zoetis Cl A (ZTS)
Hilton Worldwide Holdings (HLT)
NVR (NVR)
Booking Holdings (BKNG)
Chevron Corporation (CVX)
Tyson Foods Cl A (TSN)
Duke Energy Corp Com New (DUK)
EOG Resources (EOG)

View all positions for Edgestream Partners

Top funds holding Intra Cellular Therapies

Huntington National Bank

View all funds holding Intra Cellular Therapies